These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14529980)

  • 1. Pharmacokinetics after pulmonary artery perfusion with gemcitabine.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; De Boeck G; Guetens G; De Bruijn E; Van Schil PE
    Ann Thorac Surg; 2003 Oct; 76(4):1036-40; discussion 1040. PubMed ID: 14529980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Friedel G; Guetens G; De Bruijn EA; Van Schil PE
    J Surg Res; 2003 Feb; 109(2):118-22. PubMed ID: 12643852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and efficacy of isolated lung perfusion with gemcitabine in a rat model of pulmonary metastases.
    Van Putte BP; Hendriks JM; Romijn S; De Greef K; Van Schil PE
    Thorac Cardiovasc Surg; 2006 Mar; 54(2):129-33. PubMed ID: 16541356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified approach of administering cytostatics to the lung: more efficient isolated lung perfusion.
    van Putte BP; Hendriks JM; Guetens G; de Boeck G; de Bruijn EA; van Schil PE; Folkerts G
    Ann Thorac Surg; 2006 Sep; 82(3):1033-7. PubMed ID: 16928530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy with gemcitabine with isolated lung perfusion for the treatment of pulmonary metastases.
    Van Putte BP; Hendriks JM; Romijn S; Pauwels B; Vermorken JB; Van Schil PE
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):125-30. PubMed ID: 15999051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective pulmonary artery perfusion followed by blood flow occlusion: new challenge for the treatment of pulmonary malignancies.
    Grootenboers MJ; Schramel FM; van Boven WJ; Hendriks JM; van Schil PE; De Wit PE; Pasterkamp G; Folkerts G; van Putte BP
    Lung Cancer; 2009 Mar; 63(3):400-4. PubMed ID: 18657338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective pulmonary artery perfusion with melphalan is equal to isolated lung perfusion but superior to intravenous melphalan for the treatment of sarcoma lung metastases in a rodent model.
    Den Hengst WA; Hendriks JM; Van Hoof T; Heytens K; Guetens G; de Boeck G; Lardon F; Van Schil PE
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):341-7; discussion 347. PubMed ID: 22345285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-pass isolated lung perfusion versus recirculating isolated lung perfusion with melphalan in a rat model.
    Van Putte BP; Hendriks JM; Romijn S; Guetens G; De Boeck G; De Bruijn EA; Van Schil PE
    Ann Thorac Surg; 2002 Sep; 74(3):893-8; discussion 898. PubMed ID: 12238857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and delayed toxicity of gemcitabine administered during isolated lung perfusion: a preclinical dose-escalation study in pigs.
    Pagès PB; Derangere V; Bouchot O; Magnin G; Charon-Barra C; Lokiec F; Ghiringhelli F; Bernard A
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):228-35. PubMed ID: 25414426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.
    Koshkina NV; Kleinerman ES
    Int J Cancer; 2005 Sep; 116(3):458-63. PubMed ID: 15800950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites.
    Kuemmerle A; Decosterd LA; Buclin T; Liénard D; Stupp R; Chassot PG; Mosimann F; Lejeune F
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):331-41. PubMed ID: 18587581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer.
    van Putte BP; Grootenboers M; van Boven WJ; Hendriks JM; van Schil PE; Guetens G; De Boeck G; Pasterkamp G; Schramel F; Folkerts G
    Drug Metab Dispos; 2008 Apr; 36(4):676-81. PubMed ID: 18187564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique.
    Furrer M; Lardinois D; Thormann W; Altermatt HJ; Betticher D; Triller J; Mettler D; Althaus U; Burt ME; Ris HB
    Ann Thorac Surg; 1998 Jun; 65(6):1523-8. PubMed ID: 9647052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model.
    Van Thielen J; Wittock A; Hendriks J; den Hengst W; De Pooter C; Van den Weyngaert D; Pauwels P; Van Schil P
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):712-8. PubMed ID: 22345281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective pulmonary artery perfusion for the treatment of primary lung cancer: Improved drug exposure of the lung.
    van Putte BP; Grootenboers M; van Boven WJ; van Oosterhout M; Pasterkamp G; Folkerts G; Schramel F
    Lung Cancer; 2009 Aug; 65(2):208-13. PubMed ID: 19097670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary gemcitabine delivery for treating lung cancer: pharmacokinetics and acute lung injury aspects in animals.
    Min R; Li T; Du J; Zhang Y; Guo J; Lu WL
    Can J Physiol Pharmacol; 2008 May; 86(5):288-98. PubMed ID: 18432290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats.
    Romijn S; Hendriks JM; Van Putte BP; Guetens G; De Bruijn EA; Van Schil PE
    Eur Surg Res; 2003; 35(1):50-3. PubMed ID: 12566788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.
    Lemarie E; Vecellio L; Hureaux J; Prunier C; Valat C; Grimbert D; Boidron-Celle M; Giraudeau B; le Pape A; Pichon E; Diot P; el Houfia A; Gagnadoux F
    J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):261-70. PubMed ID: 21793717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intraperitoneal gemcitabine in a rat model.
    Pestieau SR; Stuart OA; Chang D; Jacquet P; Sugarbaker PH
    Tumori; 1998; 84(6):706-11. PubMed ID: 10080682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.